Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
Saved in:
| Title: | Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. |
|---|---|
| Authors: | Bénard F; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada. Electronic address: fbenard@bccrc.ca., Harsini S; BC Cancer Research Institute, Vancouver, BC, Canada., Wilson D; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Zukotynski K; Department of Radiology, McMaster University, Hamilton, ON, Canada., Abikhzer G; Jewish General Hospital, Montreal, QC, Canada., Turcotte E; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada., Cossette M; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada., Metser U; University Health Network, Toronto, ON, Canada., Romsa J; Division of Nuclear Medicine, London Health Sciences Centre, London, ON, Canada; St Joseph's Health Care, London, ON, Canada; Western University, London, ON, Canada., Martin M; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Mar C; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada., Saad F; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada., Soucy JP; Department of Radiology, McGill University, Montreal, QC, Canada., Eigl BJ; BC Cancer Research Institute, Vancouver, BC, Canada., Black P; Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada., Krauze A; BC Cancer Research Institute, Vancouver, BC, Canada., Burrell S; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada., Nichol A; BC Cancer Research Institute, Vancouver, BC, Canada., Tardif JC; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2022 Dec; Vol. 23 (12), pp. 1499-1507. Date of Electronic Publication: 2022 Nov 04. |
| Publication Type: | Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36343655 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Intra-individual comparison of <superscript>18</superscript>F-sodium fluoride PET-CT and <superscript>99m</superscript>Tc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bénard+F%22">Bénard F</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada. Electronic address: fbenard@bccrc.ca.<br /><searchLink fieldCode="AU" term="%22Harsini+S%22">Harsini S</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Wilson+D%22">Wilson D</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Zukotynski+K%22">Zukotynski K</searchLink>; Department of Radiology, McMaster University, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Abikhzer+G%22">Abikhzer G</searchLink>; Jewish General Hospital, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Turcotte+E%22">Turcotte E</searchLink>; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Cossette+M%22">Cossette M</searchLink>; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Metser+U%22">Metser U</searchLink>; University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Romsa+J%22">Romsa J</searchLink>; Division of Nuclear Medicine, London Health Sciences Centre, London, ON, Canada; St Joseph's Health Care, London, ON, Canada; Western University, London, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Martin+M%22">Martin M</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Mar+C%22">Mar C</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; Division of Urology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Soucy+JP%22">Soucy JP</searchLink>; Department of Radiology, McGill University, Montreal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Eigl+BJ%22">Eigl BJ</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Black+P%22">Black P</searchLink>; Department of Urological Sciences, University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Krauze+A%22">Krauze A</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Burrell+S%22">Burrell S</searchLink>; Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.<br /><searchLink fieldCode="AU" term="%22Nichol+A%22">Nichol A</searchLink>; BC Cancer Research Institute, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Tardif+JC%22">Tardif JC</searchLink>; Montreal Heart Institute, Université de Montréal, Montreal, QC, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2022 Dec; Vol. 23 (12), pp. 1499-1507. <i>Date of Electronic Publication: </i>2022 Nov 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Multicenter Study; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36343655 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(22)00642-8 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1499 Titles: – TitleFull: Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bénard F – PersonEntity: Name: NameFull: Harsini S – PersonEntity: Name: NameFull: Wilson D – PersonEntity: Name: NameFull: Zukotynski K – PersonEntity: Name: NameFull: Abikhzer G – PersonEntity: Name: NameFull: Turcotte E – PersonEntity: Name: NameFull: Cossette M – PersonEntity: Name: NameFull: Metser U – PersonEntity: Name: NameFull: Romsa J – PersonEntity: Name: NameFull: Martin M – PersonEntity: Name: NameFull: Mar C – PersonEntity: Name: NameFull: Saad F – PersonEntity: Name: NameFull: Soucy JP – PersonEntity: Name: NameFull: Eigl BJ – PersonEntity: Name: NameFull: Black P – PersonEntity: Name: NameFull: Krauze A – PersonEntity: Name: NameFull: Burrell S – PersonEntity: Name: NameFull: Nichol A – PersonEntity: Name: NameFull: Tardif JC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 23 – Type: issue Value: 12 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |